Insider Transactions in Q3 2024 at Aziyo Biologics, Inc. (AZYO)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,527
-3.28%
|
$42,108
$4.14 P/Share
|
|
Sep 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,500
+8.41%
|
-
|
|
Sep 10
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,664
-3.67%
|
$38,656
$4.14 P/Share
|
|
Sep 10
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,084
+9.32%
|
-
|
|
Sep 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,951
-6.19%
|
$15,804
$4.14 P/Share
|
|
Sep 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+16.38%
|
-
|
|
Aug 12
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
17,840
-5.8%
|
$35,680
$2.84 P/Share
|
|
Aug 12
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+13.97%
|
-
|
|
Aug 12
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,800
-23.55%
|
$31,600
$2.84 P/Share
|
|
Aug 12
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+42.7%
|
-
|
|
Aug 12
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
58,659
-20.06%
|
$117,318
$2.84 P/Share
|
|
Aug 12
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
162,500
+35.72%
|
-
|
|
Jul 31
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
105,080
+28.96%
|
$105,080
$1.43 P/Share
|
|
Jul 30
2024
|
High Cape Capital, L.P. Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,101,577
+18.76%
|
$2,101,577
$1.43 P/Share
|
|
Jul 30
2024
|
High Cape Capital, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,101,577
+18.76%
|
$2,101,577
$1.43 P/Share
|